This Mid-Cap Stock To Pay 300% Final Dividend, 600% Special Dividend, Record Date Fixed

GlaxoSmithKline Pharmaceuticals Ltd. has fixed the record date to receive dividend. In its filing to the BSE, the board stated, "Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, 8th July, 2022 as the Record Date for determining entitlement of members to final dividend for the financial year ended 31 st March, 2022. The dividend, if approved by the members will be paid on or after Wednesday, 27th July, 2022." Check other key details below:

1. GlaxoSmithKline Pharmaceuticals Ltd to pay 300% Final Dividend, 600% special dividend

The board of the company approved the dividend on May 16, 2022. In its BSE filing, the company said, "The Board has recommended a dividend of Rs. 90/- (including special dividend of Rs. 60) per equity share on face value of Rs.10 each for the year ended 31 st March 2022, subject to approval of members at 97th Annual General Meeting to be held on Tuesday, 26th July, 2022."

Ex-Dividend Date: The ex-dividend date is July 7, 2022 and record date July 8.

2. GlaxoSmithKline Pharmaceuticals Stock Outlook

The current market price of the stock is Rs 1520 apiece while the 52-week high and 52-week low of stock is Rs 1918 and Rs 1450. The stock has given a negative return of 24% in one year and a positive return of 24.79% in 5 years. The PE of the stock is 15.20 which is lesser than sector PE of 28.76. The EPS is 100.04.

3. GlaxoSmithKline Pharmaceuticals Dividend History

The company has an outstanding dividend record and declared dividend regularly for the last 5 years. If the current market price of the stock is considered at Rs 1520, the dividend yield is 5.92, which is attractive. Last year in 2021 it declared a final dividend of 300% and in 2020 it declared a special and final dividend of 200% each.

4. GlaxoSmithKline Pharmaceuticals Company Overview

The company has strong financials. The company is almost debt free. It registered a good profit growth of 40.68% CAGR in the last 5 years. It has a great return on equity record with 3 years ROE at 41.9%. The market capitalization is Rs 25,764 crore. The company has high TTM EPS growth. It spent less than 1% of its operating revenue towards interest expenditure. Revenue from operations surged to Rs 810 crore for fourth quarter compared to Rs 744 crore in the year ago period. For FY 2022, it declared a consolidated net profit from continuing operations at Rs 381 crore against Rs 287 in FY21.

5. About GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Ltd came into existence in 1924. It is operating in Pharmaceuticals sector. According to its websites, It is uniting science, technology and talent to get ahead of disease together.